Tech Company Financing Transactions
KelSie Biotech Funding Round
KelSie Biotech closed a $5 million Series A funding round on 6/3/2019. Backers included Salveo Capital, Arcadian Fund and private investors.
Transaction Overview
Company Name
Announced On
6/3/2019
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Salveo Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds for its scientific research and market expansion.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
KelSie Biotech, LLC (KelSie) is a Single Purpose Colorado Limited Liability Company headquartered in Boulder, CO. The Company was formed to pursue the research and commercial opportunities contemplated in its Worldwide Licensing Agreement with Colorado Can, LLC (dba Sievers Biotech).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Kaanta
Chief Marketing Officer
Steven Addis
Chief Operating Officer
Cameron Keluche
Chief Scientific Officer
Lia Rebits
Vice President
Christie Sievers
VP - Engineering
Xuno Gildelamadrid
VP - R & D
Vince Mathias
Browse more venture capital transactions:
Prev: 6/3/2019: Backtracks venture capital transaction
Next: 6/4/2019: AdHawk venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs